Maintenance of Baxter CVVH Prismax and Thermax system by Baxter/Vantive US Healthcare LLC (Notice of Intent to sole source)
ID: NOI-CC-24-08156Type: Presolicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNATIONAL INSTITUTES OF HEALTH - CCBETHESDA, MD, 20892, USA

NAICS

Electronic and Precision Equipment Repair and Maintenance (811210)

PSC

MAINT/REPAIR/REBUILD OF EQUIPMENT- INSTRUMENTS AND LABORATORY EQUIPMENT (J066)

Original Source

https://sam.gov/opp/f30ad991b21e457a8950013d8b0531c1/view
Timeline
    Description

    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to negotiate a sole-source contract with Vantive US Healthcare LLC for the maintenance of Baxter's Continuous Veno-Venous Hemofiltration (CVVH) devices and associated equipment. The contract will cover the maintenance of five PRISMAX CVVH hemofiltration devices and five Thermax blood warmers, ensuring compliance with the manufacturer's maintenance standards and the operational integrity of critical medical equipment used in patient care. This equipment is vital for treating patients with acute renal failure, and the contract is structured for one base year with four option years, commencing on September 23, 2024. Interested parties may submit capability statements to Lu Chang at lu-chang.lu@nih.gov by 11:00 AM EST on September 11, 2024, for consideration.

    Point(s) of Contact
    Lu Chang
    lu-chang.lu@nih.gov
    Files
    Title
    Posted
    1. Statement of Work-Bill of Materials for Prismax Service_Base plus 4 years.docx
    The document outlines a non-personnel services contract for the maintenance of medical surgical and bariatric patient beds and associated equipment for the NIH Clinical Center. The contractor is responsible for providing all necessary services, personnel, and materials for the maintenance of Baxter Prismax and Thermax Continuous Veno-Venous Hemofiltration (CVVH) machines for a period of one base year and four option years, commencing September 23, 2024. Key requirements include on-site service availability within two business days, preventive maintenance visits, and adherence to manufacturer’s specifications for service and parts. The contractor must ensure compliance with federal, state, and local regulations and provide clinical training upon equipment delivery. The aim of this RFP is to ensure reliable operation of critical medical equipment in a federal research hospital setting, showcasing the government's commitment to maintaining healthcare infrastructure and patient care standards. The document confirms the importance of maintaining high standards for medical equipment maintenance and provides a structured approach to ensure compliance and service quality over the designated contract period.
    Similar Opportunities
    MAINTENANCE AND REPAIR SERVICE AGREEMENT FOR NEXTSEQ 2000 (S/N: VH74007)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to negotiate a maintenance and repair service agreement for the Illumina NextSeq 2000 system, serial number VH74007. The contract will cover a 12-month support plan, including full maintenance for parts, labor, and travel, as well as preventative maintenance inspections, remote technical support, and software updates. This service is crucial for the Laboratory of Parasitic Diseases to ensure the operational efficiency of their sequencing equipment. Interested vendors must submit their capability statements and relevant documentation by 12:00 PM EST on November 15, 2024, via the NIH electronic Simplified Acquisition Submission System (eSASS), with all inquiries directed to Mildred Moss at mildred.moss@nih.gov or Tonia Alexander at talexander@niaid.nih.gov.
    Notice of Intent to Sole Source; Monument Medical
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to QuVA Pharma, Inc. for the procurement of compounded intravenous (IV) narcotics for patient care at the NIH Clinical Center. This acquisition aims to secure sterile compounded products that meet the quality standards necessary for ongoing patient treatment, as QuVA Pharma is the sole distributor of these specific IV narcotics in the U.S. market. Interested parties are invited to express their interest and capabilities regarding this procurement, with comments due by November 15, 2024, at 10 AM EST, directed to Kristin Nagashima at kristin.nagashima@nih.gov.
    BD Flow Cytometry System Preventative Maintenance Service
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking a contractor to provide preventative maintenance services for BD FACSLyric Clinical Flow Cytometry Systems and associated equipment. The procurement aims to ensure the operational integrity of critical laboratory instruments used for research and development in cellular therapy, which are essential for improving immunotherapy efficiency. The contract will be awarded to Becton, Dickinson and Company, the original equipment manufacturer, as they are the sole provider capable of performing necessary software updates and maintenance due to the proprietary nature of the equipment. Interested parties may submit capability statements by November 8, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.
    DocuWare License and Annual Maintenance and Software Support Services
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm-fixed price contract for DocuWare License and Annual Maintenance and Software Support Services. This procurement aims to provide ongoing support for the DocuWare software system, which is critical for managing over 80,000 active medical and donor records within the Department of Transfusion Medicine, ensuring compliance with federal regulations. The NIH has determined that only DocuWare Corporation can fulfill this requirement without incurring significant costs associated with transitioning to a new vendor, including retraining and system redevelopment. Interested parties may express their interest and capabilities to Tasha Lowe at lowet2@mail.nih.gov by November 4, 2024, at 12 PM.
    BD Biosciences Proprietary Instrumentation Package and Reagent Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to procure a proprietary instrumentation package and reagent kits from Becton, Dickinson & Company for the Department of Laboratory Medicine. This acquisition aims to secure essential supplies, including instrument rentals and quality control materials, necessary for the operation of the Hematology Flow Cytometry Service, which plays a critical role in patient care and research. The procurement is vital for maintaining the laboratory's capacity to deliver timely and accurate results, as the specified reagent kits are uniquely compatible with the existing BD Rhapsody™ single cell analysis system. Interested parties may submit capability statements to Shasheshe Goolsby at shasheshe.goolsby@nih.gov by November 14, 2024, at 6:30 AM EST, as this is a presolicitation notice and not a request for quotations.
    CYTEK AURORA 5 LASER PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking qualified contractors to provide a premium service agreement for the Cytek Aurora 5 Laser systems. The procurement includes essential services such as preventive maintenance inspections, technical support, and on-site assistance for four specific Cytek Aurora 5 Laser units, ensuring optimal performance and reliability during the contract period from March 1, 2025, to February 28, 2026. This service agreement is critical for maintaining the functionality of laboratory equipment used in vital research, reflecting the NIH's commitment to supporting scientific advancements. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 12, 2024, at 12:00 am EST, and can contact Maliaka Pinkney at maliaka.pinkney@nih.gov for further inquiries.
    Title: Global Life Sciences Sepax Cell Separation Kits
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking to award a firm fixed-price contract for the procurement of Global Life Sciences Sepax Cell Separation Kits and Ficoll Paque Premium reagents. The NIH's Department of Transfusion Medicine requires these items to support the manufacturing of cell-based therapies for patients with advanced metastatic cancer, utilizing the Sepax C-Pro Cell Processing Instruments. This acquisition is being conducted under the Simplified Acquisition Procedures, allowing for a sole-source award to Cytiva-Global Life Sciences Solutions USA LLC, with capability statements due by November 3, 2024, at 12:00 PM EST. Interested parties can direct inquiries to Sheri Eiri at sheri.eiri@nih.gov.
    6515--Intent to Sole Source Notice Hemostasis Management System
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs intends to award a sole source contract for the procurement of four Hemostasis Management Systems from InvoSurg, Inc. This acquisition is critical for the cardiac surgery department at the West Roxbury VA Medical Center, as the HMS Plus device is essential for monitoring and managing heparin anticoagulation levels during surgical procedures, thereby improving patient outcomes. The decision to sole source is based on the unique technology developed by Medtronic, which includes specialized algorithms and sensors, confirming that no comparable products are available in the market. Interested vendors must submit their qualifications to the designated contract specialist, Divianna Mathurin, by November 6, 2024, at 10:00 AM EST, as this is not a request for competitive proposals and no solicitation documents are currently available.
    CYTEK AURORA 5 LASER WITH LOADER - UV/V/B/YG/R - PREMIUM SERVICE AGREEMENT
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking quotes for a premium service agreement for a Cytek Aurora 5 laser with loader, which is essential for advanced laboratory applications. The procurement includes comprehensive maintenance services, such as preventive inspections, technical support, and on-site assistance, ensuring optimal functionality of the equipment throughout the contract period from December 1, 2024, to November 20, 2025. This acquisition is critical for supporting the NIH's research initiatives in allergy and infectious diseases, emphasizing the importance of reliable laboratory equipment and services. Interested vendors must submit their quotations via the NIAID electronic Simplified Acquisition Submission System (eSASS) by November 13, 2024, at 12:00 am EST, and can contact Maliaka Pinkney or Jesse D Weidow for further inquiries.
    Gore Medical branded stents (Brand Name restriction)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, National Institutes of Health seeks to procure specific medical devices for use in interventional radiology procedures. These are brand-restricted items, with the National Institute of Health specifying Gore Medical branded stents. The scope of work involves supplying several variants of two medical devices: Viatorr Tips Endo CX and Viabahn BX Balloon Expander Endo. The Viatorr Tips are measured in millimeters and vary in length, while the Viabahn BX Balloon Expanders are used in catheterization procedures. The medical devices are intended for minimally invasive procedures. The bill of materials provided outlines the exact models and quantities sought. Offerors must provide the following: 1 unit of Model PTB8105275, ID 00733132635016 - 8-10mmX5cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8107275, ID 00733132635030 - 8-10mmX7cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model PTB8108275, ID 00733132635047 - 8-10mmX8cm/2cm 10Fr VIATORR TIPS ENDO CX 1 unit of Model BXB083901A, ID 00733132658718 - 8MMX39MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO 1 unit of Model BXB085901A, ID 00733132658732 - 8MMX59MM 7Fr 80CM Cath RP VIABAHN BX BALLOON EXP ENDO Eligible applicants should be well-established surgical and medical instrument manufacturers (NAICS code 339112) with the ability to deliver the specified devices promptly. The evaluation of quotes will consider technical capability, price, and past performance. Quotes should be submitted to Lu Chang at lu-chang.lu@nih.gov by 5:00 PM EST on 08/01/2024, including the RFQ number (RFQ-CC-24-010258) in the subject line. Further inquiries can be directed to the same email address. This opportunity is a combined synopsis and solicitation issued under FAR Subpart 12.6. The resulting contract will be a firm fixed-price order.